Which class is typically represented by once-daily dosing in glaucoma therapy?

Boost your readiness for the Primary Open-Angle Glaucoma Test. Utilize flashcards and multiple-choice questions complete with hints and detailed explanations to enhance your understanding.

Multiple Choice

Which class is typically represented by once-daily dosing in glaucoma therapy?

Explanation:
Prostaglandin analogs are typically dosed once daily because they produce a strong and sustained reduction in intraocular pressure by increasing the outflow of aqueous humor through the uveoscleral pathway. This effect lasts roughly 24 hours, allowing a single daily dose—usually given in the evening—to maintain effective pressure control. The other classes generally have shorter durations of action or require more frequent dosing to maintain IOP lowering, such as twice daily for beta-blockers, and more frequent dosing for carbonic anhydrase inhibitors and alpha agonists. This long-lasting, once-daily profile is a defining feature of prostaglandin analogs in glaucoma therapy.

Prostaglandin analogs are typically dosed once daily because they produce a strong and sustained reduction in intraocular pressure by increasing the outflow of aqueous humor through the uveoscleral pathway. This effect lasts roughly 24 hours, allowing a single daily dose—usually given in the evening—to maintain effective pressure control. The other classes generally have shorter durations of action or require more frequent dosing to maintain IOP lowering, such as twice daily for beta-blockers, and more frequent dosing for carbonic anhydrase inhibitors and alpha agonists. This long-lasting, once-daily profile is a defining feature of prostaglandin analogs in glaucoma therapy.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy